COMMENTS TO THE GUIDELINES

COMMENTS TO THE GUIDELINES

Comments to the guidelines.

Saved in:

Bibliographic Details
Main Author:	S. R. Gilyarevsky
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Online Access:	https://www.rpcardio.online/jour/article/view/913
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RESULTS AND COMMENTS ON ADVANCE STUDY
by: S. R. Gilyarevsky
Published: (2015-12-01)

COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION
by: D. V. Nebieridze
Published: (2016-01-01)

COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES
by: An. A. Alexandrov
Published: (2015-12-01)

COMMENTS ON EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
by: S. A. Shalnova
Published: (2016-01-01)

COMMENTS ON EUROPEAN GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (2006)
by: S. Y. Martsevich
Published: (2015-12-01)

COMMENTS TO THE LATEST EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION (2007)
by: V. M. Gorbunov
Published: (2015-12-01)

UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01)

COMMENTS ON THE EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION (2010)
by: V. A. Sulimov
Published: (2016-01-01)

EDITORIAL COMMENTS ON “EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE”
Published: (2015-12-01)

COMMENTS ON GUIDELINES OF THE TASK FORCE ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY OF EUROPEAN SOCIETY OF CARDIOLOGY
by: R. I. Striyk
Published: (2016-01-01)

COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES ESC-EASD 2007
by: M. V. Shestakova
Published: (2015-12-01)

Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare
by: O. M. Drapkina, et al.
Published: (2019-09-01)

COMMENTS ON “GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE OF THE EUROPEAN SOCIETY OF CARDIOLOGY 2005”
by: V. Y. Mareev
Published: (2016-01-01)

COMMENTS ON GUIDELINES OF THE TASK FORCE ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY OF EUROPEAN SOCIETY OF CARDIOLOGY
by: O. N. Tkacheva
Published: (2016-01-01)

Novel Urethral Stricture Disease Guideline Amendment (2023) by the American Urological Association: editorial comments
by: M. I. Kogan
Published: (2023-10-01)

COMMENTS ON GUIDELINES OF AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: S. R. Gilyarevskiy
Published: (2015-12-01)

COMMENTS ON GUIDELINES OF THE TASK FORCE FOR DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE OF THE EUROPEAN SOCIETY OF CARDIOLOGY (2005)
by: V. V. Yakusevich
Published: (2016-01-01)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I
by: N. L. Kozlovskaya, et al.
Published: (2020-11-01)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II
by: N. L. Kozlovskaya, et al.
Published: (2021-02-01)

EUROPEAN GUIDELINES ON MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION 2008. WHAT CHANGED? (COMMENTS TO UPDATED)
by: R. M. Linchak, et al.
Published: (2016-01-01)

Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice
by: S. A. Shalnova
Published: (2022-01-01)

Modern Approaches to the Interpretation of the Results of Large Randomized Clinical Trials
by: S. R. Gilyarevsky
Published: (2022-07-01)

Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art
by: S. R. Gilyarevsky
Published: (2022-07-01)

Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis
by: S. R. Gilyarevsky
Published: (2021-09-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
by: S. R. Gilyarevsky
Published: (2015-12-01)

Nitrate role in cardiovascular disease management: scientific evidence and clinical practice
by: S. R. Gilyarevsky
Published: (2007-06-01)

Ticagrelor — a legend of modern cardiology
by: S. R. Gilyarevsky
Published: (2024-10-01)

Influence of standard heart failure therapy on readmission rate: opportunities and limitations in modern clinical practice
by: S. R. Gilyarevsky
Published: (2021-11-01)

Arterial Hypertension in Cardio-Renal-Metabolic Syndrome: New Targets and Proven Treatment Approaches
by: S. R. Gilyarevsky
Published: (2025-06-01)

COMMENTS ON AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov
Published: (2015-12-01)

COMMENTS ON AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: A. I. Tarzimanova
Published: (2015-12-01)

Guidelines are merely guidelines
by: Chittaranjan Andrade, et al.
Published: (2025-03-01)

Editor's Comments
by: Judith Holton
Published: (2005-11-01)

Editor’s Comments
by: Judith A. Holton
Published: (2004-11-01)

Editor’s Comments
by: Judith A. Holton
Published: (2005-06-01)

Editor′s comments
by: S Bhattacharya
Published: (2011-01-01)

Comment on Rorty
by: Akeel Bilgrami
Published: (2018-12-01)

Editorial Comment
by: Brian Rayner
Published: (2012-04-01)

Editor's comment
by: S. Bhattacharya
Published: (2011-09-01)

Editor’s Comment
Published: (2024-01-01)